Analysis of TCGA data shows that elevated YBX1 expression was highly prognostic in a cohort of 1,926 NSCLC patients (Győrffy et al., 2013; Figure 1D) and in 83 mesothelioma patients (Goswami and Nakshatri, 2014; Figure 1E). Here, YBX1 is linked to mesothelioma.